Table 2.

TNF-α, IL-6 and characteristics of the 1914 population

		TNF-α pg/ml	IL-6 pg/ml
Gender
Men	n= 158	4·1 (3·1–5·0)	3·5 (2·4–5·5)
Women	n = 175	4·2 (3·2–5·2)	3·2 (2·2–5·4)
		P = 0·3	P = 0·5
Smoking status
Never	n = 109	4·2 (3·2–5·0)	3·0 (2·1–4·6)
Previous	n = 133	4·1 (3·0–5·1)	3·3 (2·2–5·5)
Current	n = 91	4·1 (3·2–5·1)	4·3 (2·6–5·9)
		P = 0·6	P = 0·008
Physical activity
Mainly sitting	n = 25	5·0 (3·9–5·6)	6·2 (4·3–10·0)
Light/moderate	n = 248	4·2 (3·2–5·2)	3·3 (2·3–5·5)
> Moderate	n = 60	3·5 (2·9–4·4)	2·8 (2·0–4·4)
		P = 0·01	P = 0·001
Total cholesterol	n= 333	R = − 0·07; P = 0·2	R = − 0·26; P < 0·0005
Blood pressure
Systolic	n = 333	R = − 0·039; P = 0·5	R = − 0·10; P = 0·06
Diastolic	n = 333	R = − 0·058; P = 0·3	R = − 0·12; P = 0·03
BMI
Men	n = 153	R = 0·12; P = 0·1	R = − 0·008; P = 0·9
Women	n = 161	R = 0·24; P = 0·002	R = 0·15; P = 0·07
CVD
Yes	n = 63	4·2 (3·5–5·1)	4·4 (2·6–5·9)
No	n = 270	4·1 (3·2–5·1)	3·1 (2·2–5·3)
		P = 0·6	P = 0·4
Other chronic diseases
Yes (pooled)	n = 47	4·0 (3·2–5·6)	3·5 (2·3–5·1)
No	n = 286	4·1 (3·2–5·0)	3·3 (2·3–5·5)
		P = 0·8	P = 0·4
Cancer
Yes	n = 25	4·5 (3·4–5·6)	3·3 (2·1–4·3)
No	n = 308	4·1 (3·2–5·0)	3·3 (2·3–5·5)
		P = 0·4	P = 0·2
DM
Yes	n = 12	3·7 (3·2–5·3)	4·0 (2·7–5·5)
No	n = 321	4·1 (3·2–5·1)	3·3 (2·3–5·5)
		P = 0·9	P = 1·0
CPD
Yes	n = 11	3·6 (2·8–5·0)	3·5 (2·3–4·6)
No	n = 322	4·1 (3·2–5·1)	3·3 (2·3–5·5)
		P = 0·6	P = 0·09
Anti-inflammatory drugs
Yes	n = 133	4·1 (3·2–5·1)	3·6 (2·5–5·2)
No	n = 200	4·2 (3·2–5·0)	3·0 (2·2–5·5)
		P = 0·7	P = 0·7

Medians and interquartile range (25th−75th percentile) are shown. R, Pearson's correlation coefficient. CVD, cardiovascular diseases. Other chronic diseases are defined as one of the following diagnoses: cancer, diabetes mellitus (DM) or chronic obstructive pulmonary diseases (CPD). Anti-inflammatory drugs: daily intake of non-steroid anti-inflammatory drugs, acetyl salicylic acid or corticosteroids.